Table 2.
Comparison of baseline characteristics between the D-PMI group and the non-D-PMI group.
| Variables | D-PMI group (n=90) Number or median value (range) |
Non-D-PMI group (n=92) Number or median value (range) |
P value |
|---|---|---|---|
| Age (years) | 71 (48-93) | 67 (41-85) | 0.2754 |
| Gender, male / female | 63 / 27 | 48 / 44 | 0.0134 |
| Body mass index (kg/m2) | 22.2 (14.7-33.1) | 23.3 (18.7-30.6) | 0.0020 |
| Tumor number, single / multiple | 75 / 15 | 70 / 22 | 0.2703 |
| Maximum tumor size (cm) | 1.5 (0.7-3.5) | 1.4 (0.7-3.0) | 0.1530 |
| Child-Pugh, A / B or C | 66 / 24 | 71 / 21 | 0.6078 |
| Presence of ascites, yes / no | 15 / 75 | 11 / 81 | 0.4024 |
| Total bilirubin (mg/dl) | 0.9 (0.3-5.5) | 0.9 (0.4-3.4) | 0.8818 |
| Serum albumin (g/dl) | 3.6 (1.8-4.7) | 3.7 (2.7-4.7) | 0.0217 |
| Prothrombin time (%) | 80.4 (50.9-108.4) | 81.1 (50.4-108) | 0.9769 |
| Platelet count (×104/mm3) | 10.0 (3.2-24.2) | 10.45 (2.5-25.3) | 0.4891 |
| Serum creatinine (mg/dl) | 0.79 (0.38-6.6) | 0.69 (0.39-4.6) | 0.0043 |
| C reactive protein (mg/dl) | 0.1 (0-3.0) | 0.1 (0-0.7) | 0.1161 |
| AST (IU/l) | 43.5 (16-140) | 42.5 (16-139) | 0.7447 |
| ALT (IU/l) | 34 (10-117) | 35.5 (12-151) | 0.3929 |
| Total cholesterol (mg/dl) | 149.5 (74-274) | 152 (93-229) | 0.6436 |
| Triglyceride (mg/dl) | 82.5 (30-656) | 96 (30-250) | 0.0698 |
| Fasting blood glucose (mg/dl) | 100 (72-296) | 99.5 (65-229) | 0.6261 |
| BTR | 4.3 (1.77-17.39) | 4.62 (1.8-10.53) | 0.8375 |
| Serum ammonia (μg/dl) | 37 (5-114) | 39 (10-149) | 0.2180 |
| Alpha fetoprotein (ng/ml) | 8.55 (0.6-1293) | 9.4 (1.2-2593) | 0.1804 |
| DCP (mAU/ml) | 31 (5-2700) | 23 (7-3460) | 0.8753 |
Data are expressed as number or median (range). D-PMI; decreased psoas muscle index, AST; aspartate aminotransferase, ALT; alanine aminotransferase, BTR; branched-chain amino acid to tyrosine ratio, DCP; des-γ-carboxy prothrombin